Printivo Group Jsc
Sofia
About Printivo Group Jsc
Printivo is a 3D-bioprinting startup company in a mission to radically improve drug-testing and personalized medical therapies, paving the way to a complete printed human organ.Currently we are situated in Sofia, Bulgaria. Our motto – “We print life” is the quintessence of our main goal namely to fabricate and design native-like human tissues and organs. Our inspiration is driven by the huge necessity of finding solutions for the growing humanitarian problem with shortage of organ transplants. Hundreds of people die each day, in this very minute in fact, failing to receive organ transplantation. This life-giving act must be accessible and affordable to each person and we are ready to take this difficult, uncertain and long way to fulfill their needs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $572.7K
- Funding stage: Seed
- Last round: Seed (Mar 2021)
- Website: printivo.eu
- Phone: [email protected]
Industries & Categories
3D Printing, Biopharma, Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/printivo-group-jsc-144085 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.